US OptionsDetailed Quotes
CRBP241220P17500
- 1.85
- +0.35+23.33%
15min DelayClose Nov 22 16:00 ET
1.85High1.85Low
1.85Open1.50Pre Close1 Volume125 Open Interest17.50Strike Price185.00Turnover69.07%IV10.42%PremiumDec 20, 2024Expiry Date0.03Intrinsic Value100Multiplier26DDays to Expiry1.82Extrinsic Value100Contract SizeAmericanOptions Type-0.4611Delta0.1234Gamma13.70Leverage Ratio-0.0238Theta-0.0060Rho-6.32Eff Leverage0.0185Vega
Corbus Pharmaceuticals Stock Discussion
Sign in to post a comment
$Corbus Pharmaceuticals (CRBP.US)$
wow drop 62%. 😲
wow drop 62%. 😲
1
1
Got in at $16, this is gonna be a pretty long hold for me, wanna see how it plays out
5
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Hello Mooers! ![]()
A quick recap for the month ending April 30, 2024.
![]()
Ten stocks with >300% YTD
![]()
$Swvl Holdings (SWVL.US)$718.40%
![]()
$Root Inc (ROOT.US)$564.60%
![]()
$Elevation Oncology (ELEV.US)$561.08%
![]()
$JanOne (JAN.US)$554.05%
![]()
$GeneDx Holdings (WGS.US)$520.71%
![]()
$Corbus Pharmaceuticals (CRBP.US)$513.25%
![]()
$AGBA Group (AGBA.US)$482.90%
![]()
$Janux Therapeutics (JANX.US)$431.22%
![]()
$Dave Inc (DAVE.US)$4...
A quick recap for the month ending April 30, 2024.
4
1
$Corbus Pharmaceuticals (CRBP.US)$ Very strong uptrend, let's go high!
Dr. Smethurst's appointment, with his vast experience in oncology therapeutics, is viewed positively for Corbus. His leadership is anticipated to be key in the upcoming US dose escalation study for CRB-701 and the progression of other Corbus assets.
$Corbus Pharmaceuticals (CRBP.US)$ 50$/19$=2.63:1 ?
No comment yet
71013325 : because they shaking out all those that fold easily because it was an easy profit to predict